Variant report
Variant | nsv511188 |
---|---|
Chromosome Location | chr2:173001058-173006031 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr2:172999674..173002716-chr2:173011251..173014037,3 | K562 | blood: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs182971273 | chr2:173001849-173001850 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs149668194 | chr2:173001871-173001872 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs6735574 | chr2:173001874-173001875 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
4 | rs114329980 | chr2:173001898-173001899 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs559717852 | chr2:173002037-173002038 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs578105696 | chr2:173002094-173002095 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs545946304 | chr2:173002099-173002100 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs145460382 | chr2:173002115-173002116 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs531380078 | chr2:173002130-173002131 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs549808128 | chr2:173002142-173002143 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs537290974 | chr2:173002167-173002168 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs561687448 | chr2:173002168-173002169 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs529192959 | chr2:173002172-173002173 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs74360255 | chr2:173002210-173002211 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs35627950 | chr2:173002213-173002214 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs537598882 | chr2:173002214-173002215 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs541929368 | chr2:173002215-173002216 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs56282600 | chr2:173002223-173002224 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs138930534 | chr2:173002240-173002241 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs377659663 | chr2:173002246-173002247 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs565765291 | chr2:173002292-173002293 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs532945563 | chr2:173002313-173002314 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs551502138 | chr2:173002314-173002315 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs7585949 | chr2:173002392-173002393 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
25 | rs139604196 | chr2:173002398-173002399 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs11885116 | chr2:173002403-173002404 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs191957073 | chr2:173002415-173002416 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs577223873 | chr2:173002417-173002418 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs535033637 | chr2:173002429-173002430 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs183060309 | chr2:173002434-173002435 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs565258747 | chr2:173002447-173002448 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs145115603 | chr2:173002490-173002491 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs563644226 | chr2:173002505-173002506 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs374637592 | chr2:173002507-173002508 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs12468831 | chr2:173002541-173002542 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
36 | rs147937991 | chr2:173002563-173002564 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs56140108 | chr2:173002580-173002581 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
38 | rs187745052 | chr2:173002640-173002641 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs74937629 | chr2:173002670-173002671 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs78295709 | chr2:173002671-173002672 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs528860691 | chr2:173002702-173002703 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs541003132 | chr2:173002804-173002805 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs559590769 | chr2:173002839-173002840 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs533007217 | chr2:173002845-173002846 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs114275429 | chr2:173002875-173002876 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs561092387 | chr2:173002926-173002927 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs569477198 | chr2:173002931-173002932 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs192581946 | chr2:173002964-173002965 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs535100177 | chr2:173002966-173002967 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs549435679 | chr2:173002971-173002972 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Breast cancer | 17603634 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Ependymoma | 16718352 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Autism | 18522746 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Breast cancer | 16272173 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Autism | 16446308 | CNVD |
Autism | 19401682 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Lung cancer | 18438408 | CNVD |
Glioblastoma | 21080181 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Prostate cancer | 16573809 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Prostate cancer | 18632612 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Donnai-Barrow syndrome | 21085971 | CNVD |
Breast cancer | 21045282 | CNVD |
Limb abnormalities | 22140379 | CNVD |
Sudden cardiac death | 19188705 | CNVD |
Breast cancer | 21364760 | CNVD |
Chronic myeloid leukemia | 21384125 | CNVD |
Non-syndromic sensorineural hearing loss | 18451855 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:173001800-173002200 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
2 | chr2:173002200-173012600 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
3 | chr2:173004400-173007200 | Weak transcription | Fetal Brain Male | brain |